| (+)-N-[(S)-α-(Chloromethyl)benzyl]acetamide |
| N-[(S)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]acetamide |
| (+)-N-[(S)-2-Chloro-1-methylethyl]-N-methylformamide |
| (-)-N-[(S)-3-Chloro-1-methyl-2-oxopropyl]phthalimide |
| N-[(S)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]-4-hydroxybenzeneacetamide |
| N-{4-[(1S)-2-CHLORO-1-HYDROXYETHYL]PHENYL}-N-METHYLMETHANESULFONAMIDE |
| N-{4-[(1S)-2-CHLORO-1-HYDROXYETHYL]PHENYL}-N-ETHYLMETHANESULFONAMIDE |
| N-{4-[(1S)-2-CHLORO-1-HYDROXYETHYL]PHENYL}METHANESULFONAMIDE |
| N-(2-{4-[(1S)-2-CHLORO-1-HYDROXYETHYL]PHENYL}ETHYL)METHANESULFONAMIDE |
| 96426-93-6 | N-[[(1S)-11-Bromo-1,2,7,8,13,13bβ-hexahydro-10-hydroxy[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol]-1α-yl]-2-hydroxyacetamide |
| N-[(1S)-2β-Bromocycloheptan-1α-yl]acetamide |
| (-)-N-[(S)-2-Bromohexanoyl]glycine |
| (-)-N-[(S)-2-Bromopropionyl]glycine |
| (+)-N-[(S)-α-(Bromomethyl)benzyl]acetamide |
| (-)-N-[(S)-3-Bromo-1-methyl-2-oxopropyl]phthalimide |
| Nα-[(2S)-3-(5-Bromo-1H-indol-3-yl)-2-aminopropionyl]-L-tryptophan |
| (-)-N-[(S)-α-(Bromoacetyl)-p-methoxyphenethyl]phthalimide |
| (-)-N-[(S)-2-Bromobutyryl]glycine |
| (-)-N-[(S)-2-Bromo-4-methylvaleryl]glycine |
| N-[(1S)-2β-Bromocyclopentan-1α-yl]acetamide |
| (-)-N-[(S)-2-Bromo-3-methylbutyryl]glycine |
| 1253690-78-6 | 普瑞巴林杂质B |
| 1222966-43-9 | N-[(8Α,9S)-奎宁-9-基]-N'-[(2R)-2-吡咯烷基甲基]硫脲 |
| 1222966-34-8 | N-(8Α,9S)-奎宁-9-基]-N'-[(2S)-2-吡咯烷基甲基]硫脲 |
| 157654-67-6 | NSC632839hydrochloride |
| 1177865-17-6 | NSC23766 |
| NR-LU-10 antibody |
| (+)-N-[[(R)-N-Benzyloxycarbonyl-3-cyano-D-alanyl]oxy]succinimide |
| 1005450-55-4 | 西那卡塞中间体 |
| N-[(R)-1-(1-Naphtyl)ethyl]carbamic acid (E)-3-cyclohexylallyl ester |
| (-)-N-[(R)-2-(2-Naphtyl)propionyl]-4-morpholinecarbothioamide |
| (+)-N-[(R)-1-(1-Naphtyl)ethyl]formamide |
| N-[(R)-1-(1-NAPHTHYL)ETHYL]PHTHALAMIC ACID |
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67
|
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa14-30
|
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67 Control Peptide (KLH)
|
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67 Control Peptide
|
| N-[(S)-Butan-2-yl]adenosine |
| N-[[(2S)-1-Butyl-2-pyrrolidinyl]methyl]-2-methoxy-5-sulfamoylbenzamide |
| N-[3-[(S)-2-Butyrylamino-3-(4-hydroxy-3,5-diiodophenyl)propanoylamino]propyl]-N'-[3-[(S)-2-amino-4-guanidinobutyrylamino]propyl]butane-1,4-diamine |
| NSCL protein |
| N-[[(2S)-1-Decylpyrrolidin-2α-yl]methyl]-2-methoxy-5-sulfamoylbenzamide |
| 83889-68-3 | N-(2-(S-coenzyme A)acetyl)spermidine |
| 116-44-9 | 磺胺吡嗪 |
| N-[[[(5S)-5α-[[6-Deoxy-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6β,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen]-2-yl]carbonyl]-D-alanine methyl ester |
| N-[[[(5S)-5α-[[6-Deoxy-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6β,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen]-2-yl]carbonyl]-D-alanine |
| Nα-[(2R)-2-(Morpholinocarbonylmethyl)-3-(1-naphthalenyl)propionyl]-L-His-[(2R,3S)-3-amino*-2-hydroxy-5-methylhexanoic acid]isopropyl ester |
| Nα-[(2R)-3-(Morpholinocarbonyl)-2-(1-naphtylmethyl)propionyl]-L-histidine methyl ester |
| NRN1 (full length)
|
| NSE |
| NQ Y15 |
| 19547-88-7 | (R)-甲基2-乙酰胺基-3-(乙酰基硫基)丙酸酯 |
| 82576-33-8 | N-[(1S)-4-(diaminomethylideneamino)-1-[(9-ethylcarbazol-3-yl)carbamoyl ]butyl]benzamide |
| 1420-88-8 | N,S-二乙酰半胱胺 |
| N,S-DIACETYLCYSTEINE |
| 3-N'-[(S)-3,6-Diaminohexanoyl]amphotericin B methyl ester |
| (+)-N-[(S)-4-Diazo-1-methyl-3-oxobutyl]phthalimide |
| (+)-N-[(S)-4-Diazo-2-methyl-3-oxobutyl]phthalimide |
| 3-N'-[(S)-2,4-Diaminobutyryl]amphotericin B methyl ester |
| N-[(S)-1-(Diazoacetyl)-3-methylbutyl]-4-methylbenzenesulfonamide |
| N-[3-[(S)-2,6-Diaminohexanoylamino]propyl]-N'-[3-[(S)-2-butyrylamino-3-(4-hydroxy-3,5-diiodophenyl)propanoylamino]propyl]butane-1,4-diamine |
| N-[3-[(S)-2,6-Diaminohexanoylamino]propyl]-N'-[3-[(S)-2-butyrylamino-3-[4-hydroxy-3,5-di[(125I)iodo]phenyl]propanoylamino]propyl]butane-1,4-diamine |
| (+)-N-[(S)-5-Diazo-3-methyl-4-oxopentyl]phthalimide |
| (-)-N-[(S)-6-Diazo-3-methyl-5-oxohexyl]phthalimide |
| (-)-N-[(S)-1-(Diazoacetyl)butyl]phthalimide |
| (-)-N-[(S)-α-Diazoacetyl-p-methoxyphenethyl]phthalimide |
| (-)-N-[(S)-1,2-Dicyclohexylethyl]maleimide |
| 90245-73-1 | N-[(S)-1,2-Dicarboxyethyl]-D-glutamic acid |
| (-)-N-[(S)-1,2-Di(cyclohexyl)ethyl]phthalimide |
| 135545-99-2 | N-[2-[[(2S)-2α,6-Dicarboxy-1,2,3,4-tetrahydropyridin]-4-ylidene]ethylidene]glycine |
| (-)-N-[(S)-1,2-Dicyclohexylethyl]-2-methylenesuccinimide |
| N-[(S)-1-(2,4-DICHLOROPHENYL)ETHYL]-2-CYANO-3,3-DIMETHYLBUTANAMIDE |
| 1655-62-5 | N,S-DI(2,4-DNP)-L-CYSTEINE |
| (-)-N-[(S)-α-Diethoxymethyl-p-methoxyphenethyl]phthalimide |
| 905580-86-1 | (S)-N-(2,3-二氢-1H-茚-1-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 |
| N-[[(S)-2,3-Dihydro-1H-inden]-1β-yl]adenosine |
| N-[[(S)-2,3-Dihydro-5-methoxy-1H-inden]-1β-yl]adenosine |
| N-[(1S)-1-[[[(2,3-Dihydro-1H-inden)-2-yl][[[2-(trifluoroacetyl)propan-2-yl]carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide |
| (+)-N-[(S)-3,β-Dihydroxyphenethyl]-N-methylacetamide |
| N-[[(S)-2,3-Dihydro-5-butoxy-1H-inden]-1β-yl]adenosine |
| (+)-N-[(S)-β,3-Dihydroxy-4-nitrophenethyl]-N-methylacetamide |
| N-[(1S)-1-[[[(2,3-Dihydro-1H-inden)-2-yl][[(2-oxo-3,3,3-trifluoropropyl)carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide |
| NSD2 (human recombinant) |
| 230961-08-7 | UK 356618 |
| 15524-62-6 | N-[(20S)-20-(Dimethylamino)-16β-hydroxy-4,4,14-trimethyl-11-oxo-9,19-cyclo-5α-pregnan-3β-yl]benzamide |
| 17934-60-0 | N-[(20S)-4,14-Dimethyl-20-(dimethylamino)-16β-hydroxy-4β-(hydroxymethyl)-9β,19-cyclo-5α-pregnan-3β-yl]benzamide |
| N-[(5S,6β,7β,10α)-2,10-Dimethyl-7-isopropylspiro[4.5]dec-1-en-6-yl]formamide |
| (-)-N-[(S)-1-(5,8-Dimethyl-2-naphtyl)ethyl]benzamide |
| N-[(2S)-2,4-Dimethyl-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide |
| 24608-95-5 | N-[[S,(+)]-2-(3,3-Dimethylpiperidino)-1-methylethyl]-N-(2-pyridyl)propionamide |
| N-[(2S)-2,4-Dimethyl-2-[[[(2S)-pyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide |
| (-)-N-[(S)-1-(3,4-Dimethoxybenzoyl)ethyl]phthalimide |
| (+)-N-[(S)-3,4-Dimethoxy-α-methylphenethyl]-p-toluenesulfonamide |
| 4947-53-9 | N-[(20S)-20-(Dimethylamino)-16α-hydroxy-4α-(hydroxymethyl)-4,14-dimethyl-11-oxo-9β,19-cyclo-5α-pregnan-3β-yl]-2-methylpropanamide |
| (+)-N-[(S)-1,2-Dimethylpropyl]-4-nitrobenzamide |
| N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-2,2-DIMETHYLPROPANAMIDE |
| N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-2,2-DIPHENYLACETAMIDE |
| N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-4-(ETHYLTHIO)BENZAMIDE |
| N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-4-NITROBENZAMIDE |
| N4-{[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}pyrimidine-4,5-diamine |